ALZHEIMER’S DRUG DEVELOPMENT COMPANY COGNITION THERAPEUTICS APPOINTS KENNETH I. MOCH PRESIDENT & CEO
Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed...…
Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed...…
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net